Madrigal Pharmaceuticals (MDGL) Cash from Investing Activities (2009 - 2026)
Madrigal Pharmaceuticals (MDGL) recorded Cash from Investing Activities of $93.79 million in Q3 2026, compared with -$207 million a year earlier and up 174.3% from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Cash from Investing Activities (2009 - 2026) Analysis & Trends
On a TTM basis, Madrigal Pharmaceuticals' Cash from Investing Activities came in at $347.76 million as of Sep 30, 2026; for FY2025, it came in at $32.32 million.
- Annual Cash from Investing Activities has a five-year compound annual growth rate of -27.4% (FY2020 to FY2025).
- Across earlier years, Cash from Investing Activities came in at -$274.39 million in FY2024, -$502.52 million in FY2023, $206.69 million in FY2022 and -$5.06 million in FY2021.
- Quarterly Cash from Investing Activities has ranged from -$362.12 million in Q4 2023 to $192.19 million in Q1 2026 over the past five years.
- Per Business Quant, the preceding three quarters came in at $34.2 million (Q2 2026), $192.19 million (Q1 2026) and $27.58 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -8.30 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -2.71 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -10.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -1.32 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -649.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -244.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.03 Bn |
| 10 | Madrigal Pharmaceuticals | 12.65 Bn | 9.06 Bn | 393.45 Mn | 93.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 93.79 Mn |
| Jun 30, 2026 | 34.20 Mn |
| Mar 31, 2026 | 192.19 Mn |
| Dec 31, 2025 | 27.58 Mn |
| Sep 30, 2025 | -207.00 Mn |
| Jun 30, 2025 | 47.86 Mn |
| Mar 31, 2025 | 163.88 Mn |
| Dec 31, 2024 | -47.95 Mn |
| Sep 30, 2024 | -202.39 Mn |
| Jun 30, 2024 | -122.10 Mn |
| Mar 31, 2024 | 98.05 Mn |
| Dec 31, 2023 | -362.12 Mn |
| Sep 30, 2023 | 50.20 Mn |
| Jun 30, 2023 | -3.73 Mn |
| Mar 31, 2023 | -186.86 Mn |
| Dec 31, 2022 | 66.39 Mn |
| Sep 30, 2022 | 65.14 Mn |
| Jun 30, 2022 | 19.24 Mn |
| Mar 31, 2022 | 55.93 Mn |
| Dec 31, 2021 | 15.64 Mn |
API Access
Madrigal Pharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();